Britain's health regulator has approved Moderna Inc's COVID-19 vaccine for use in children aged 12 to 17 years, it said on Tuesday.
The approval comes more than two months after Pfizer and German partner BioNTech's COVID-19 vaccine got a regulatory nod for use in children aged 12 to 15.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3